- Research works
- 0 ▼ 100% vs 2013–17
- Citations
- 17 43.6 per fractional work
- Top-10% rate
- 15.4% record average 16.5%
Not ranked overall: Dance Biopharm (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Dance Biopharm (United States) publish most on?
By volume: Advancements in Transdermal Drug Delivery, Advanced Drug Delivery Systems, Inhalation and Respiratory Drug Delivery and Diabetes Treatment and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
- 2 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
- 3 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
- 4 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 5 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 6 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 19% is written across borders.
Other research institutions in Brisbane
- Hitachi (United States)
- Second Genome (United States)
- Myovant Sciences (United States)
- Mammoth Biosciences (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.